vs

Side-by-side financial comparison of CareDx, Inc. (CDNA) and LTC PROPERTIES INC (LTC). Click either name above to swap in a different company.

CareDx, Inc. is the larger business by last-quarter revenue ($117.7M vs $84.3M, roughly 1.4× LTC PROPERTIES INC). LTC PROPERTIES INC runs the higher net margin — 123.0% vs 2.4%, a 120.6% gap on every dollar of revenue. On growth, LTC PROPERTIES INC posted the faster year-over-year revenue change (60.3% vs 39.0%). LTC PROPERTIES INC produced more free cash flow last quarter ($128.7M vs $514.0K). Over the past eight quarters, LTC PROPERTIES INC's revenue compounded faster (28.1% CAGR vs 12.9%).

CareDx, Inc. is a leading precision medicine company dedicated to organ transplant patient care. It develops and commercializes diagnostic tests for rejection surveillance, digital health management tools, and supportive clinical services, catering to transplant clinicians, patients, and healthcare systems across North America and European core markets.

LTC Properties Inc is a U.S.-based real estate investment trust (REIT) that owns, finances, and manages seniors housing and healthcare-related real estate assets. Its core portfolio includes assisted living facilities, skilled nursing properties, memory care centers, and independent living communities for senior care and healthcare service operators.

CDNA vs LTC — Head-to-Head

Bigger by revenue
CDNA
CDNA
1.4× larger
CDNA
$117.7M
$84.3M
LTC
Growing faster (revenue YoY)
LTC
LTC
+21.3% gap
LTC
60.3%
39.0%
CDNA
Higher net margin
LTC
LTC
120.6% more per $
LTC
123.0%
2.4%
CDNA
More free cash flow
LTC
LTC
$128.2M more FCF
LTC
$128.7M
$514.0K
CDNA
Faster 2-yr revenue CAGR
LTC
LTC
Annualised
LTC
28.1%
12.9%
CDNA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CDNA
CDNA
LTC
LTC
Revenue
$117.7M
$84.3M
Net Profit
$2.8M
$103.7M
Gross Margin
Operating Margin
1.0%
Net Margin
2.4%
123.0%
Revenue YoY
39.0%
60.3%
Net Profit YoY
429.1%
EPS (diluted)
$0.05
$2.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDNA
CDNA
LTC
LTC
Q1 26
$117.7M
Q4 25
$108.4M
$84.3M
Q3 25
$100.1M
$69.3M
Q2 25
$86.7M
$60.2M
Q1 25
$84.7M
$49.0M
Q4 24
$86.6M
$52.6M
Q3 24
$82.9M
$55.8M
Q2 24
$92.3M
$50.1M
Net Profit
CDNA
CDNA
LTC
LTC
Q1 26
$2.8M
Q4 25
$-4.1M
$103.7M
Q3 25
$1.7M
$-20.0M
Q2 25
$-8.6M
$15.1M
Q1 25
$-10.4M
$20.7M
Q4 24
$87.7M
$19.6M
Q3 24
$-10.6M
$29.4M
Q2 24
$-4.6M
$19.4M
Operating Margin
CDNA
CDNA
LTC
LTC
Q1 26
1.0%
Q4 25
-5.6%
Q3 25
-0.2%
71.9%
Q2 25
-12.8%
80.5%
Q1 25
-15.8%
37.8%
Q4 24
97.5%
Q3 24
-16.6%
95.5%
Q2 24
-7.9%
38.0%
Net Margin
CDNA
CDNA
LTC
LTC
Q1 26
2.4%
Q4 25
-3.8%
123.0%
Q3 25
1.7%
-28.9%
Q2 25
-9.9%
25.1%
Q1 25
-12.2%
42.2%
Q4 24
101.3%
37.3%
Q3 24
-12.8%
52.6%
Q2 24
-5.0%
38.6%
EPS (diluted)
CDNA
CDNA
LTC
LTC
Q1 26
$0.05
Q4 25
$-0.08
$2.19
Q3 25
$0.03
$-0.44
Q2 25
$-0.16
$0.32
Q1 25
$-0.19
$0.45
Q4 24
$1.60
$0.38
Q3 24
$-0.20
$0.66
Q2 24
$-0.09
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDNA
CDNA
LTC
LTC
Cash + ST InvestmentsLiquidity on hand
$77.9M
$14.4M
Total DebtLower is stronger
$842.2M
Stockholders' EquityBook value
$1.1B
Total Assets
$411.1M
$2.1B
Debt / EquityLower = less leverage
0.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDNA
CDNA
LTC
LTC
Q1 26
$77.9M
Q4 25
$177.2M
$14.4M
Q3 25
$194.2M
$17.9M
Q2 25
$186.3M
$7.6M
Q1 25
$230.9M
$23.3M
Q4 24
$260.7M
$9.4M
Q3 24
$240.9M
$35.0M
Q2 24
$228.9M
$6.2M
Total Debt
CDNA
CDNA
LTC
LTC
Q1 26
Q4 25
$842.2M
Q3 25
$944.5M
Q2 25
$696.5M
Q1 25
$682.2M
Q4 24
$684.6M
Q3 24
$0
$785.3M
Q2 24
$0
$861.0M
Stockholders' Equity
CDNA
CDNA
LTC
LTC
Q1 26
Q4 25
$303.1M
$1.1B
Q3 25
$311.1M
$957.9M
Q2 25
$327.4M
$957.5M
Q1 25
$379.3M
$961.9M
Q4 24
$378.4M
$960.6M
Q3 24
$273.2M
$947.8M
Q2 24
$264.7M
$889.1M
Total Assets
CDNA
CDNA
LTC
LTC
Q1 26
$411.1M
Q4 25
$413.2M
$2.1B
Q3 25
$432.3M
$2.0B
Q2 25
$444.3M
$1.8B
Q1 25
$489.6M
$1.8B
Q4 24
$491.1M
$1.8B
Q3 24
$477.0M
$1.9B
Q2 24
$466.8M
$1.9B
Debt / Equity
CDNA
CDNA
LTC
LTC
Q1 26
Q4 25
0.78×
Q3 25
0.99×
Q2 25
0.73×
Q1 25
0.71×
Q4 24
0.71×
Q3 24
0.00×
0.83×
Q2 24
0.00×
0.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDNA
CDNA
LTC
LTC
Operating Cash FlowLast quarter
$4.3M
$136.0M
Free Cash FlowOCF − Capex
$514.0K
$128.7M
FCF MarginFCF / Revenue
0.4%
152.7%
Capex IntensityCapex / Revenue
8.6%
Cash ConversionOCF / Net Profit
1.54×
1.31×
TTM Free Cash FlowTrailing 4 quarters
$220.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDNA
CDNA
LTC
LTC
Q1 26
$4.3M
Q4 25
$21.4M
$136.0M
Q3 25
$37.4M
$38.4M
Q2 25
$9.9M
$30.0M
Q1 25
$-26.6M
$29.6M
Q4 24
$21.9M
$125.9M
Q3 24
$12.5M
$34.0M
Q2 24
$18.9M
$37.0M
Free Cash Flow
CDNA
CDNA
LTC
LTC
Q1 26
$514.0K
Q4 25
$128.7M
Q3 25
$34.3M
Q2 25
$28.9M
Q1 25
$28.2M
Q4 24
$112.2M
Q3 24
$27.7M
Q2 24
$34.7M
FCF Margin
CDNA
CDNA
LTC
LTC
Q1 26
0.4%
Q4 25
152.7%
Q3 25
49.4%
Q2 25
47.9%
Q1 25
57.6%
Q4 24
213.4%
Q3 24
49.7%
Q2 24
69.1%
Capex Intensity
CDNA
CDNA
LTC
LTC
Q1 26
Q4 25
8.6%
Q3 25
6.0%
Q2 25
1.9%
Q1 25
2.7%
Q4 24
26.0%
Q3 24
11.2%
Q2 24
4.6%
Cash Conversion
CDNA
CDNA
LTC
LTC
Q1 26
1.54×
Q4 25
1.31×
Q3 25
22.30×
Q2 25
1.99×
Q1 25
1.43×
Q4 24
0.25×
6.43×
Q3 24
1.16×
Q2 24
1.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDNA
CDNA

Financial Results Total$85.0M72%
Patient and digital solutions revenue$16.0M14%
Product revenue$10.3M9%
Other$6.4M5%

LTC
LTC

Seniors Housing Operating Portfolio Segment$72.1M86%
Other$12.2M14%

Related Comparisons